GYRE THERAPEUTICS, INC. - COM (GYRE)

Q2 2024 13F Holders as of 6/30/2024

Type / Class
Equity / COM
Number of holders
30
Total Shares
1.26M
Shares change
+438K
Total reported value, excl. options
$15M
Value change
+$4.35M
Put/Call ratio
0
Number of buys
23
Number of sells
-10
Price
$11.93
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.